GENTURI, INC.

Medtech · Defunct

micro- and nanofluidic DNA sizing platform using fluorescence burst analysis of single molecules in sub-micrometer channels

Grants
$1.3M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · A Low-Cost Platform for Routine High-Accuracy Sizing of Nucleic Acid Samples with 100 bp - 100 Mbp Dynamic Range$146,126
Federal grantDepartment of Health and Human Services · Phase II · A Low-Cost Platform for Routine High-Accuracy Sizing of Nucleic Acid Samples with 100 bp - 100 Mbp Dynamic Range$764,760
Federal grantDepartment of Health and Human Services · Phase I · A Rapid, Low-Cost Application of High-Resolution DNA Mapping for Cell Line Identification$149,894
Federal grantDepartment of Health and Human Services · Phase II · A Low-Cost Platform for Routine High-Accuracy Sizing of Nucleic Acid Samples with 100 bp - 100 Mbp Dynamic Range$200,102
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1503Persist Inc.—$30K
1504VOLATYLIX INC——
1505Mozarc Medical Management Holding LLC—$22M
1506GENTURI, INC.——
1507Onnix Global Inc.—$30M
1508ASTERION AI INC.——
1509Mindset Integrated Co—$500K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 7
  • Duty Cycle Optimization In Single-molecule Detectionapplication
  • High Density Nanofluidicsapplication
  • High Density Nanofluidicsapplication
  • Duty Cycle Optimization In Single-molecule Detectionapplication
  • Duty Cycle Optimization In Single-molecule Detectionapplication
  • High Density Nanofluidicsapplication
  • High Density Nanofluidicsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.